PALM SPRINGS, California — A new sodium channel blocker, CNV1014802, reduces neuropathic pain from lumbosacral radiculopathy, a phase 2 trial shows. Patients taking the drug improved by about 1 point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results